Astana's WorldTour licence in jeopardy after another failed drug test

Cycling's governing body will ask the Licence Commission to review Astana's management as another rider fails anti-doping test

Astana chases on stage nine of the 2014 Tour de France

(Image credit: Graham Watson)

Astana's place in the WorldTour looks under threat as the UCI ask the Licence Commission to review the team's management and anti-doping policies after a third rider fails an anti-doping test.

Following on from riders Maxim and Valentin Iglinskiy, who both tested positive for blood booster EPO in August, llya Davidenok of the Continental Team Astana tested positive for anabolic androgenic steroids at the Tour de l'Avenir at the end of the same month.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Richard Windsor

Follow on Twitter: @richwindy

Richard is digital editor of Cycling Weekly. Joining the team in 2013, Richard became editor of the website in 2014 and coordinates site content and strategy, leading the news team in coverage of the world's biggest races and working with the tech editor to deliver comprehensive buying guides, reviews, and the latest product news.

An occasional racer, Richard spends most of his time preparing for long-distance touring rides these days, or getting out to the Surrey Hills on the weekend on his Specialized Tarmac SL6 (with an obligatory pub stop of course).